Back To: Home : Featured Technology : PCR/qPCR

CLICK HERE FOR WHAT'S NEW IN:
 

Biomedical Diagnostics to distribute Asuragenís oncology products in France
May 2010
SHARING OPTIONS:

AUSTIN, TexasóAsuragen Inc. in April appointed Biomedical Diagnostics SA, a medical diagnostic company in Europe, as its exclusive distributor of Signature Oncology Products in France. The portfolio comprises multiplex assays for the detection of mutations in solid and hematologic malignancies, including a research assay for KRAS and BRAF mutations, the LTx CE marked IVD assay to detect fusion transcripts in total RNA from whole blood or bone marrow to aid in the clinical diagnosis of translocation positive leukemias and an assay for the simultaneous detection of the most common NPM1 Mutations. All of these assays utilize multiplex RT-PCR followed by multiplex detection on the Luminex 100 IS or 200 System. Financial terms of the deal were not disclosed.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.